The Impact of Lovenox Prophylaxis and Other Anticoagulants on Microvascular Free Flap Outcomes
Lovenox prophylaxis does not appear to impact overall flap survival but does confer a small increase in hematoma risk. There were higher rates of complications among patients on therapeutic heparin. Patients who require anticoagulation for other medical comorbidities are nearly 4 times as likely to develop hematomas and should be counseled accordingly.
Authors
- Gavin Young (ORCID: https://orcid.org/0000-0001-8552-0467)
- Farshid Taghizadeh (ORCID: https://orcid.org/0000-0002-5174-2608)
- Skylar Trott (ORCID: https://orcid.org/0000-0003-0628-6882)
- Daniel Clayburgh (ORCID: https://orcid.org/0000-0002-3296-4926)
- Sara Yang (ORCID: https://orcid.org/0000-0001-8949-1421)
- Mark K. Wax (ORCID: https://orcid.org/0000-0003-0250-8636)
- Hannah Smith (ORCID: https://orcid.org/0000-0002-7966-2538)
- Kavita Bhatnagar
Institutions
- Oregon Health & Science University (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1002/ohn.1160
- Citations
- 2
- Primary Topic
- Reconstructive Surgery and Microvascular Techniques
- Type
- article
- Field-Weighted Citation Impact
- 4.01